Last $1.54 USD
Change Today -0.02 / -1.28%
Volume 387.0K
STEM On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 08/21/14 All times are local (Market data is delayed by at least 15 minutes).

stemcells inc (STEM) Snapshot

Open
$1.56
Previous Close
$1.56
Day High
$1.56
Day Low
$1.53
52 Week High
07/3/14 - $2.43
52 Week Low
04/15/14 - $1.15
Market Cap
105.7M
Average Volume 10 Days
794.7K
EPS TTM
$-0.66
Shares Outstanding
68.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for STEMCELLS INC (STEM)

stemcells inc (STEM) Related Businessweek News

No Related Businessweek News Found

stemcells inc (STEM) Details

StemCells, Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of stem cell therapeutics, and related tools and technologies for stem cell-based research and drug discovery and development. It develops HuCNS-SC cells that completed Phase I clinical trial in pelizaeus-merzbacher disease, a fatal myelination disorder in brain; completed a Phase I clinical trial in infantile and late infantile neuronal ceroid lipofuscinosis, which is a neurodegenerative disorder of the brain; and conducting preclinical studies in alzheimer’s disease. The company is also developing HuCNS-SC cells that are in Phase I/II clinical trial for the treatment of chronic spinal cord injury, as well as for dry age-related macular degeneration. In addition, it is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company markets a range of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. Its proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. The company serves researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.

58 Employees
Last Reported Date: 03/13/14
Founded in 1988

stemcells inc (STEM) Top Compensated Officers

Chief Executive Officer, President, Director,...
Total Annual Compensation: $835.8K
Executive Vice President of Scientific & Stra...
Total Annual Compensation: $457.3K
General Counsel and Secretary
Total Annual Compensation: $377.0K
Compensation as of Fiscal Year 2013.

stemcells inc (STEM) Key Developments

StemCells Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

StemCells Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported total revenue of $242,000 compared to $281,000 a year ago. Loss from operations was $8,104,000 compared to $6,221,000 a year ago. Net loss was $12,115,000 or $0.22 per basic and diluted share compared to $5,868,000 or $0.15 per basic and diluted share a year ago. The decrease of 14% from 2013 to 2014 in total revenue was primarily due to lower revenue from SC Proven product sales in the second quarter of 2014. Net cash usage for the second quarter was approximately $8.6 million. For the six months, the company reported total revenue of $581,000 compared to $566,000 a year ago. Loss from operations was $15,004,000 compared to $12,478,000 a year ago. Net loss was $19,736,000 or $0.36 per basic and diluted share compared to $12,285,000 or $0.32 per basic and diluted share a year ago. Net cash usage has been approximately $12.7 million.

StemCells Inc., Q2 2014 Earnings Call, Aug 12, 2014

StemCells Inc., Q2 2014 Earnings Call, Aug 12, 2014

StemCells Inc. to Report Q2, 2014 Results on Aug 12, 2014

StemCells Inc. announced that they will report Q2, 2014 results at 5:00 PM, Eastern Standard Time on Aug 12, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STEM:US $1.54 USD -0.02

STEM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aastrom Biosciences Inc $3.64 USD -0.07
Biorestorative Therapies Inc $0.30 USD 0.00
BioTime Inc $2.85 USD -0.04
IntelliCell BioSciences Inc $0.0013 USD 0.0001
International Stem Cell Corp $0.10 USD -0.003
View Industry Companies
 

Industry Analysis

STEM

Industry Average

Valuation STEM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 71.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 60.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STEMCELLS INC, please visit www.stemcellsinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.